Advertisement
Canada markets open in 6 hours
  • S&P/TSX

    21,837.18
    -12.02 (-0.06%)
     
  • S&P 500

    5,149.42
    +32.33 (+0.63%)
     
  • DOW

    38,790.43
    +75.63 (+0.20%)
     
  • CAD/USD

    0.7374
    -0.0015 (-0.21%)
     
  • CRUDE OIL

    82.67
    -0.05 (-0.06%)
     
  • Bitcoin CAD

    87,303.17
    -5,190.81 (-5.61%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,159.00
    -5.30 (-0.24%)
     
  • RUSSELL 2000

    2,024.74
    -14.58 (-0.72%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,185.50
    -46.00 (-0.25%)
     
  • VOLATILITY

    14.50
    +0.17 (+1.19%)
     
  • FTSE

    7,722.55
    -4.87 (-0.06%)
     
  • NIKKEI 225

    40,003.60
    +263.20 (+0.66%)
     
  • CAD/EUR

    0.6784
    -0.0008 (-0.12%)
     

Starbucks expansion plans, Pfizer hit with record fine, Dave & Buster's hits all-time high

Here are some of the stocks the Yahoo Finance team will be watching for you today.

Starbucks (SBUX) announced at its investor day that it plans to open 12,000 stores globally in the next five years and set an annual growth target of 10%. This comes after Howard Schultz said last week he would step down as CEO next year to focus on the company’s high-end coffee shops.

The CEOs of AT&T (T) and Time Warner (TWX) are getting ready to defend their proposed $85 billion merger before members of the Senate Judiciary Committee this morning. The size of the merger has raised concerns about the impact it will have on consumers and the cable industry.

Dave & Buster’s (PLAY) shares soared to all-time high after the restaurant-entertainment chain raised its revenue outlook for the year after delivering a beat on both its top and bottom lines for the third quarter. Overall revenue soared nearly 19% thanks to stronger-than-expected same-store sales growth.

ADVERTISEMENT

Pfizer (PFE) shares are in focus this morning. A UK competition regulator fined the US drugmaker a record $107 million for charging the country’s National Health Service astronomically high prices for its anti-epilepsy drug. Pfizer plans to appeal the verdict.

Apple (AAPL) suffered a setback in its patent battle with Samsung. The Supreme Court ruled that a lower court needs to reconsider the $400 million worth of damages the company was ordered to pay Apple for infringing on iPhone design patents.